Literature DB >> 25244410

Tick Bite Prophylaxis: Results From a 2012 Survey of Healthcare Providers.

A E Perea1, A F Hinckley1, P S Mead1.   

Abstract

In a recent national survey, over 30% of healthcare providers (HCPs) reported prescribing tick bite prophylaxis in the previous year. To clarify provider practices, we surveyed HCPs to determine how frequently and for what reasons they prescribed tick bite prophylaxis. We included four questions regarding tick bite prophylaxis in the DocStyles 2012 survey, a computer-administered questionnaire of 2205 US primary care physicians, paediatricians and nurse practitioners. Responses in 14 states with high Lyme disease incidence (high LDI) were compared with responses from other states (low LDI). Overall, 56.4% of 1485 providers reported prescribing tick bite prophylaxis at least once in the previous year, including 73.9% of HCPs in high LDI and 48.2% in low LDI states. The reasons given were 'to prevent Lyme disease' (76.9%), 'patients request it' (40.4%) and 'to prevent other tickborne diseases' (29.4%). Among HCPs who provided prophylaxis, 45.2% did so despite feeling that it was not indicated. Given a hypothetical scenario involving a patient with an attached tick, 38.1% of HCPs from high LDI states and 15.1% from low LDI states would prescribe a single dose of doxycycline; 19.0% from high LDI states and 27.5% from low LDI states would prescribe a full course of doxycycline. HCPs prescribe tick bite prophylaxis frequently in areas where Lyme disease is rare and for tickborne diseases for which it has not been shown effective. HCPs may be unaware of current tick bite prophylaxis guidelines or find them difficult to implement. More information is needed regarding the efficacy of tick bite prophylaxis for diseases other than Lyme disease. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  DocStyles; Lyme disease; antibiotic prophylaxis; tick bite; tickborne disease

Mesh:

Substances:

Year:  2014        PMID: 25244410      PMCID: PMC4652931          DOI: 10.1111/zph.12159

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  10 in total

1.  Summary of notifiable diseases--United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-01       Impact factor: 17.586

2.  Prophylactic treatment of Rocky Mountain spotted fever.

Authors:  R H Kenyon; R G Williams; C N Oster; C E Pedersen
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

3.  Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.

Authors:  Stephen Warshafsky; David H Lee; Louise K Francois; John Nowakowski; Robert B Nadelman; Gary P Wormser
Journal:  J Antimicrob Chemother       Date:  2010-04-09       Impact factor: 5.790

4.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

5.  Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.

Authors:  Alice S Chapman; Johan S Bakken; Scott M Folk; Christopher D Paddock; Karen C Bloch; Allan Krusell; Daniel J Sexton; Steven C Buckingham; Gary S Marshall; Gregory A Storch; Gregory A Dasch; Jennifer H McQuiston; David L Swerdlow; Stephen J Dumler; William L Nicholson; David H Walker; Marina E Eremeeva; Christopher A Ohl
Journal:  MMWR Recomm Rep       Date:  2006-03-31

6.  U.S. healthcare providers' experience with Lyme and other tick-borne diseases.

Authors:  Meghan E Brett; Alison F Hinckley; Emily C Zielinski-Gutierrez; Paul S Mead
Journal:  Ticks Tick Borne Dis       Date:  2014-04-06       Impact factor: 3.744

7.  Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.

Authors:  R B Nadelman; J Nowakowski; D Fish; R C Falco; K Freeman; D McKenna; P Welch; R Marcus; M E Agüero-Rosenfeld; D T Dennis; G P Wormser
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

8.  The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior.

Authors:  R Mangione-Smith; E A McGlynn; M N Elliott; P Krogstad; R H Brook
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

9.  Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription.

Authors:  J G Scott; D Cohen; B DiCicco-Bloom; A J Orzano; C R Jaen; B F Crabtree
Journal:  J Fam Pract       Date:  2001-10       Impact factor: 0.493

10.  Doxycycline propylaxis for human scrub typhus.

Authors:  J C Twartz; A Shirai; G Selvaraju; J P Saunders; D L Huxsoll; M G Groves
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

  10 in total
  3 in total

1.  U.S. public's experience with ticks and tick-borne diseases: Results from national HealthStyles surveys.

Authors:  Sarah A Hook; Christina A Nelson; Paul S Mead
Journal:  Ticks Tick Borne Dis       Date:  2015-04-15       Impact factor: 3.744

2.  Diagnosis, Treatment, and Prevention Practices for Lyme Disease by Clinicians, United States, 2013-2015.

Authors:  Alyssa R Beck; Grace E Marx; Alison F Hinckley
Journal:  Public Health Rep       Date:  2021-02-04       Impact factor: 3.117

3.  Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015.

Authors:  Salima Gasmi; Nicholas H Ogden; Patrick A Leighton; Ariane Adam-Poupart; François Milord; L Robbin Lindsay; Sapha Barkati; Karine Thivierge
Journal:  BMC Fam Pract       Date:  2017-05-22       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.